Background and purpose: Sleeve lobectomy is considered an acceptable surgery for patients with central lung cancer
and can preserve more lung functions because of the reservation of the normal lung tissues. It can also be an alternative surgery for patients with cardiac or pulmonary contraindications to pneumonectomy. Methods: In this study
we conducted a retrospective study to examine the safety and efficacy of sleeve lobectomy
particularly in relation with different stages. Results: In the group
the overall survival (OS) rate was 66.92%
and disease-free survival (DFS) rate was 18.4%. Conclusion: Sleeve lobectomy has low mortality and complication rates. It has good preservation of pulmonary function for tumor resection. It can be used as an alternative to pneumonectomy for patients with non-small cell lung cancer (NSCLC).
Survival analysis of 6 737 surgically resected gastric cancer cases in China from a large single institution hospital-based cancer registry database
Construction and validation of the survival prediction model for patients with cutaneous spindle cell melanoma
Survival report of 13.7 thousand surgical colorectal cancer patients from a large single hospital-based cancer registry
Changing long-term survival of Chinese breast cancer patients—experience from a large single institution hospital based cancer registry with 35 thousand patients
Prognostic significance of peripheral absolute monocyte count, platelet-lymphocyte ratio in patients with primary nasal natural killer/T-cell lymphoma
Related Author
Ying ZHENG
Jie SHEN
Jiangli WANG
Zezhou WANG
Miao MO
Changming ZHOU
Jing YUAN
Dazhi XU
Related Institution
Department of Cancer Prevention, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University
Department of Gastric Surgery, Division 1, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University
Shanghai Engineering Research Center of Artificial Intelligence Technology for Tumor Diseases